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in sporadic lung cancer*
LINA MARCELA BARRERA, BIOL1**, LIZETH MARELLY ÁLVAREZ, BIOL.1**,
MIGUEL IGNACIO ROLDÁN, MD2, HÉCTOR ORTEGA, MD3, OMAR TRIANA, PHD4,
ALONSO MARTÍNEZ, PHD5
SUMMARY
Introduction: Loss of Heterozygocity (LOH) in the short arm of human chromosome 3 (3p) is a frequent event in different
types of sporadic tumors, including lung cancer (LC).
Aim: To determine 3p LOH in LC samples using 17 microsatellite markers.
Methodology: In a pilot study on volunteers, thirteen LC biopsies (tumor tissue) and 4 ml of blood (normal tissue) from
the same patient were collected.  DNA extraction and Polymerase Chain Reaction (PCR) were performed with 17
microsatellite markers to analyze LOH. Amplified fragments were run on 6% denaturalizing polyacrilamide gels and were
visualized by using silver stain. Descriptive analysis was performed for each region on the 3p chromosome.
Results: All tumors were informative for one or more of the analyzed markers. LOH was found in one or more loci in eleven
samples (84.6%). The markers with major LOH were UBE1L (23.1%), D3S1317, D3S1300, D3S1284, D3S1274, D3S3049,
and D3S1577 (15.4%). Three samples showed microsatellite instability (changes in the length of the microsatellite) in
different loci. The percentages of LOH for the regions of 3p were: 17.6 % for 3p24-25, 11.62% for 3p21-22, 20% for 3p13-
14, and 18.42% for the 3p12 region.
Conclusions: Chromosomal regions with allelic loss were identified where probably other GSTs involved in the
development of the LC are localized.  It should increases sample size and marker number in order to narrow a minimal region
and to identify a unknown gene involved in LC.
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Pérdida de heterocigocidad en el brazo corto del cromosoma 3 humano en cáncer esporádico de pulmón
RESUMEN
Introducción: La pérdida de heterocigocidad (LOH) en el brazo corto del cromosoma 3 (3p) humano es un evento
frecuente en diferentes tipos de tumores esporádicos, incluyendo cáncer de pulmón (CP).
Objetivo: Determinar la LOH de 3p en muestras de CP, con 17 marcadores microsatelitales.
Metodología: En un estudio piloto en voluntarios, se recolectaron 13 biopsias de CP (tejido tumoral) y 4 ml de sangre
periférica (tejido normal) del mismo paciente, se extrajo el ADN y se realizaron reacciones en cadena de la polimerasa (PCR)
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con 17 marcadores microsatelitales para analizar LOH. Los
fragmentos amplificados se corrieron en geles de
poliacrilamida desnaturalizante al 6% y se visualizaron por
medio de la coloración de tinción de plata. El análisis
descriptivo se realizó para cada región estudiada en el
cromosoma 3p.
 Resultados: Todos los tumores fueron informati-
vos para uno o más de los marcadores analizados. Se
encontró LOH en uno o más loci en 11 muestras
(84.6%). Los marcadores con mayores LOH fueron
UBE1L (23.1%), D3S1317, D3S1300, D3S1284,
D3S1274, D3S3049 y D3S1577 con 15.4%. Tres mues-
tras presentaron inestabilidad microsatelital (cambios
en la longitud del microsatélite) en diferentes loci. Los
porcentajes de LOH para las regiones de 3p fueron:
17.6 % para 3p24-25, 11.6% para 3p21-22, 20% para
3p13-14 y 18.4% para la región 3p12.
Conclusiones: Se identificaron regiones cromo-
sómicas con pérdida alélica donde es probable que se
localicen otros GST involucrados en el desarrollo de
CP, diferentes de los ya identificados como VHL,
RASSF1A, FHIT y DUTTI, entre otros. Se debe aumen-
tar el número de muestras y de marcadores para delimi-
tar una región mínima e identificar algún gen no descri-
to implicado en la carcinogénesis de pulmón.
Colomb Med. 2010; 41: 358-66
Palabras clave: Neoplasia pulmonar (NP); Marcadores
microsatelitales; Pérdida de heterocigocidad (LOH).
Lung cancer (LC) represents 12.6% (1’448,000) of
new cancer cases in the world; it is the most frequent
cause of mortality due to cancer in males (848,132 per
year) and the second in females (330,786 per year)1. In
Colombia nearly 3868 cases/year are diagnosed in a
proportion of two men for one woman and there are
approximately 3895 deaths per year, which places it as
the third cause of deaths due to cancer2. LC originates
in the respiratory epithelium and it is classified as
Small-Cell Lung Cancer (SCLC) and Non-Small-Cell
Lung Cancer (NSCLC). Cigarette smoking is the main
risk factor causing LC and it is involved in up to 71%
of deaths due to LC in Western countries3. In addition
to tobacco, there are other factors involved in the
development of LC related to life style and occupational
risk factors that imply being in contact with carcinogens4.
Tumor Suppressor Genes (TSG) are implied in
carcinogenesis, like also proto-oncogene and DNA
repair genes; the existence of TSG is suspected when
observing frequent loss of specific regions in a specific
chromosome. If we correlate absence of locus with
tumor development, it can be supposed that its presence
avoids tumorigenesis. For a cell to acquire tumor pheno-
type, loss of TSG function is required, which may or
may not be accompanied by over expression of proto-
oncogene and there is also accumulation of additional
mutations in other genes5,6.
Karyotypes and analysis of Loss of Heterozygosity
(LOH) are routine procedures to detect DNA deletion
and serve as TSG location indicators. Several authors
postulating LOH occurs because there is loss of the
whole chromosome due to inappropriate chromosome
segregation during mitosis or that it is also produced
because genetic alterations change chromosome
structures. Other authors suggesting mitotic recom-
bination and gene conversion are additional mechanisms
causing LOH7. Detecting genetic changes in lung
epithelium is important in order to identify patients at
high risk of developing LC. Pre-neoplastic and pre-
invasive lesions possess changes like LOH in 3p, 9p,
8p, and 17p arms and mutations in some oncogenes and
TSG. Recent studies suggest that these changes are also
observed in bronchial epithelium of normal appearance
in smokers and former smokers and are even detected in
sputum samples obtained from these patients, which
serve as molecular biomarkers for early detection of
LC8. The aim of this study is to determine LOH in
human chromosome 3p in 13 samples of sporadic LC
using 17 microsatellite markers.
METHODOLOGY
This pilot study was carried out with 13 volunteer
patients diagnosed with sporadic LC, without chemo-
therapy and/or radiotherapy treatment from whom we
obtained an informed signed consent previously appro-
ved by the respective ethics committees. Through a
structured interview, we obtained information on their
individual life styles, including cigarette and alcohol
consumption. 4 ml of peripheral blood was obtained
from each patient (normal control), together with a
biopsy of the tumor, which was classified according to
the American Joint Committee on Cancer (AJCC). 10
mg of tumor tissue were separated and homogenized
with Proteinase K (Sigma, USA), and lymphocytes
were isolated from peripheral blood through a centrifuge
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gradient of FICOLL HISTOPAQUE® 1077 (Sigma,
USA). Afterwards, the DNA was extracted from the
paired samples of tumor and normal tissue with the
Wizard® Genomic DNA Purification kit (Promega,
USA). The DNA was quantified and diluted to a 50 ng/
µl concentration.
LOH in 3p was determined using 17 microsatellite
markers synthesized by Integrated DNA Technologies,
Inc, USA (Table 1) and optimized in previous studies9,10.
Standard Polymerase Chain Reaction (PCR) was carried
out in 25µl final volume containing 50 ng/µl of genomic
DNA; 1X Ammonium buffer; 1.25 mM of MgCl2; 12.5
pmol of each primer pair; 0.04 mM of each
deoxynucleotide (dTTP, dGTP, dCTP, and dATP); 0.5
U of Taq Recombinant polymerase (Fermentas Life
Sciences, USA). Amplification was done on a PT-100
thermocycler (Sensoquest, Germany) with the following
thermal profile: initial denaturation at 94°C for five
min, followed by 35 cycles consisting of denaturation
at 94°C for 30 s, a specific annealing temperature for
each set of primer for 30 s, (Table 1), and an extension
at 72°C for 1 min; followed by a final extension at 72°C
for 10 min.
The amplified products were run on 6% denatu-
ralizing polyacrilamide gels. The gels were preheated
at 1700 volts for 30 min. Formamide loading buffer in
a 5:1 ratio was added to the PCR products, which were
denaturized at 95°C for 5 min and loading into the gel.
Electrophoresis was carried out in a vertical chamber
(Sequi-Gen, Bio-Rad, USA) during 4-6 hours at constant
voltage depending on size of the fragment to accomplish
an adequate separation. Then, silver nitrate staining
was carried out. Briefly, the gel was washed in 10%
acetic acid for 30 min with constant agitation, rinsed in
ddH2O for 2 min; then it was incubated into 1% nitric
acid during 15 min and again rinsed with ddH2O.
Thereafter, the gel was submerged in a silver nitrate and
formaldehyde solution for 30 min and rinsed with
ddH2O for 2 min. Then, it was introduced onto a pre-
cold developing solution (4ºC) of sodium carbonate,
*www.ncbi.nlm.nig.gov/entrez/query.fcgi?db=unists                 Distances from telomere to centromere
Table 1
Characteristics of 3p microsatellite markers
D3S1304 TTCGCTCTTTGATAGGC ATTTCATTTGTAATTTACTAGCAG 50 250-270 19.61
D3S1537 CTATAAAATGGCTATACCCAG CTATTTTTGGACCCAGTAACC 55 212 23.18
D3S1317 TACAAGTTCAGTGGAGAACC CCTCCAGGCCATACACAGTCA 58 160 27.68
UBE1 GGAGCCAGCTCAGAGCATAG CCAGTGCAAACAGGAACCAAG 58 108-117 67.94
D3S2407 TGTACCCTATAGAAGTAAGACCAGG GGAGTTCAAGGTTACAGTCAGC 55 214 67.94
CAP1 TAGATGAGGAAACTGAGGCC GGCATAACAGCCATTTGGCA 60 170 70.89
D3S1568 CCATGAACAGAACCTCCCTA CCGCTGTCCTGCTGTAAG 58 280 70.89
D3S1621 CCAAGGAAGGGTTTTACTTA CCTCACTACTCCTGGAATTG 55 140 70.89
D3S1289 AAAGCAACTTGTAAGAGAGCA CTCCTAGATATAATCACTGGCA 55 197-215 73.73
D3S2408 ACCTGCTAACACTGACAGTGC ACACAGATACCAATGGGTGG 55 189 76.58
D3S1300 AGCTCACATTCTAGTCAGCCT GCCAATTCCCCAGATG 56 217-241 82.20
D3S1284 GCCTTGGGGGTAAATACTCT GGAATTACAGGCCACTGCTC 58 155 102.10
D3S1274 TTATACATCAGTCTCTGGGAAACAC TACTGTGCATATAGGTTCCTGTGA 55 130 107.18
D3S3049 AAAGACACAAGGGGTTTTAGG TTGCACATTCCATGAACATC 52 170 107.18
D3S1577 TCAAAAGTTGCATCGC TCCATTACAATCCCCTG 50 230 107.43
D3S2494 AGTTCCTAACATGTGTCAGGTAAG CTGGCAGTCTCCAAACATCAGAAC 56 252-253 124.16
D3S2510 TTGCCACGGATGTAAGGAAGACAATG TGATTCAGACCCAGTTAACAG 55 500 125.00
Primer
Forward sequence (5’-3’)
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formaldehyde, and sodium thiosulphate until the bands
were visualized. Finally, the reaction was stopped with
10% acetic acid and rinsed with running water. The gel
was transferred to Whatman 3MM paper and vacuum
dried for 90 min at 80°C. LOH was assigned if an allele
was absent or exhibited an altered signal in tumor
sample with relationship to normal DNA allelic ratio. A
descriptive analysis was conducted for each region
studied in chromosome 3p.
RESULTS
Patient characteristics are described in Table 2.
Patients were in an age range between 49 and 78 years,
with a mean of 67 years of age. All were active smokers
from an early age, with consumption over 20 cigarettes/
day (high consumption). Of these, nine individuals
(69.2%) regularly consumed alcoholic beverages
(moderate consumption, between 50 and 100 g/day).
Two samples (15.4%) were classified as SCLC and ten
(77%) were classified as NSCLC. NSCLC samples
were classified according to the cellular type involved
in malignant transformation; six samples were squamous
cell carcinoma, two bronchogenic squamous cell carci-
nomas, one adenocarcinoma, and one squamous cell
carcinoma. One of the samples presented non-malignant
dysplasia; however, molecular study showed important
changes which were considered for analyses.
All tumors were informative for one or more of the
markers analyzed. In 11 of 13 samples (84.6%) LOH
was found in one or more loci. The markers with major
LOH were: UBE1L (23.1%), D3S1317, D3S1300,
D3S1284, D3S1274, D3S3049, and D3S1577 with
15.4%  (Figure 1). LOH percentages for each 3p regions
were calculated as: number of LOH in the region/
number of informative cases in the same region. The
percentages obtained were: 17.6% for 3p24-25, 11.6%
for 3p21-22, 20% for 3p13-14, and 18.4% for 3p12
region. In three samples, NT44, NT45, and NT48,
microsatellite instability (MSI) and LOH were
simultaneously found (Figures 2 and 3). Two squamous
cell carcinoma-type NSCLC tumors did not present
allelic loss for any loci. One patient, NT55, was found
with allelic loss of microsatellite marker D3S1577,
flanked by markers CAP1 and D3S3049, both showed
allelic retention (Figure 4).
Figure 1. Percentages of LOH for 17 microsatellite markers in 13 samples of human lung cancer
362
Colombia Médica                  Vol. 41 Nº 4, 2010 (Octubre-Diciembre)
Table 2
Patients and tumor characteristics
NT 43 F 60 High No Non-malignant
dysplasia
NT 44 M 73 High Moderate NSCLC
NT 45 F 49 High No SCLC
NT 46 M 73 High Moderate NSCLC
NT 47 M 74 High Moderate NSCLC
NT 48 M 76 High Moderate NSCLC
NT 49 F 61 High No NSCLC
NT 50 M 67 High Moderate NSCLC
NT 51 M 78 High No SCLC
NT 52 M 64 High Moderate NSCLC
NT 53 M 70 High Moderate NSCLC
NT 54 M 68 High Moderate NSCLC
NT 55 M 62 High Moderate NSCLC





F: female;    M: Male;     NSCLC: non-small-cell lung cancer;     SCLC: small-cell lung cancer
Figure 2. LOH and MSI patterns detected in 13 cases of lung cancer
 Loss of heterozygosity;      Retention of heterozygosity;     Not informative;        Microsatellite instability
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Figure 3. a) Examples of LOH in patients with LC. b) Examples of MSI; b.1) and b.2) located in the
3p21-22 region and b.3) in the 3p12 region. Arrows indicate chromosomal alteration
DISCUSSION
Tobacco smoking is the main risk factor for deve-
loping LC and other types of cancer11,12. Furthermore,
consumption of alcoholic beverages is also an important
factor in lung, mouth, larynx, pharynx, stomach, and
liver tumorigenesis when consumption overpasses 100
g/day4. Patients studied were active smokers for several
years (high consumption) and were moderate alcohol
drinkers. A meta-analysis performed by Lubin et al.13,
calculated that 25-68% of cancers associated to upper
aero-digestive tract are related to alcohol consumption
and the incidence increases in up to 80% when is
combined with cigarette smoking. The same study
reports that the combined effect of alcohol and cigarette
smoking increases the risk of developing LC up to 80
times, which indicates the multiplicative effect of both.
It is suggesting the first carcinogenic event is caused by
tobacco and gives the affected cell a selective advantage
that together with alcohol consumption favors
accumulation of new cell mutations and alterations that
in the end would manifest as a tumor phenotype.
In the 3p24-25 region, three LOH (18.8%) were
found of the total found in 13 patients. Previous reports
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located and identified some genes related to tumor
development as VHL, VHI, and RARβ, which are flanked
by microsatellites D3S1537 and D3S1317. Miyakis et
al.14, demonstrated that mutations and LOH in VHL
gene are not common events in NSCLC; nevertheless,
they found LOH in regions adjacent to this gene in
squamous cell carcinoma and adenocarcinomas at 74.6%
and 49.3%, respectively. It is postulated that other still
not identified genes located in this region would be
genetically altered and involved in tumorigenesis. Our
results are agree with the high frequency of LOH in this
region; although, it is not comparable with previous
study probably due to the low number of microsatellites
employed to cover this 4.5 cM region.
For the 3p21-22 region, we used six microsatellite
markers covering a distance of 16.58 cM, where five
LOH (11.7%) were found. This region contains the
Lung Cancer Tumor Suppressor Gene Region 1
(LCTSGR1), where genes as RASSF1A, HYAL2/LUCA,
FUS1/TUSC2, 101F6/CYB561D2, and CPR2L/CPRL2/
TUSC4, are located. Previous studies reporting
RASSF1A gene presents LOH in up to 75% of NSCLC15.
Other authors reported that HYAL2/LUCA, FUS1/
TUSC2, 101F6/CYB561D2, and CPR2L/CPRL2/
TUSC4 genes presented genetic changes (LOH, point
mutations, deletions, and epigenetic changes in different
types of cancers and tumor-cell lines); however, they
did not identify LOH in LC biopsies5,16. The results
herein reported show a high frequency of LOH; even
though, we cannot guarantee that it corresponds to
RASSF1A gene or to another gene located in this region,
which will be the next step to study in our samples.
In 3p13-14 region with a distance of 19.9 cM between
markers D3S1300 and D3S1284, four cases of LOH
(20%) were identified. The most fragile site of the
genome is located in this region and the FHIT gene is
located here, which is involved in development of
different types of cancer. Zabarosky et al.17, refer to
some studies demonstrated that up to 50% of LC cases
present LOH in FHIT gene. They also reported that
another gene located in this region, FOXP1, presents
loss of expression in 51% of cancers analyzed; however,
they did not report LOH in LC samples. Our results are
similar to those reported for this region. 3p12 region,
contains the Lung Cancer Tumor Suppressor Gene
Region 2 (LCTSGR2), where the DUTT1 gene is located;
to analyze this region, we used five markers covering a
17.82-cM distance and found the greatest number of
LOH, 7 (18.5%) for this study. Dallol et al.18,
demonstrated that hypermethylation occurs in DUTT1
gene in up to 4% of LCs and observed LOH for some
markers in 3p12 region. Our results show a smaller
Figure 4. Case NT55. a) The central image shows LOH in the D3S1577 marker, flanked by the
microsatellite markers CAP1 and D3S3049, which present retention. b) Schematic representation of
the location of the microsatellite markers and the distance in cM
RETENTION RETENTIONLOH
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difference than that reported in similar studies19. For
this region, patients NT43, NT51, and NT55 showed
LOH in a microsatellite marker flanked by two markers
that showed retention. It suggesting this region is very
important in the development of tumorigenesis and
there could be a yet unidentified candidate  TSG (Figu-
re 2).
There were three cases of microsatellite instability
(MSI) in markers D3S2407, D3S1289, and D3S1274
(Figure 2). MSI are changes in the length of the micro-
satellite marker by insertions or deletions of repetitions
in tumor tissue when compared with normal tissue;
these alterations may occur due to defects in the DNA
repair system (Mismatch Repair - MMR). Nevertheless,
others studies identified microsatellite alterations like
LOH and MSI in 80.5% of LC samples for chromo-
somes 3p, 5q, 8p, 9p, 9q, and 17q. Additionally, studies
reporting genes involved in DNA repair do not present
changes in their expression pattern in SCLC cellular
lines and that MSI is a bio-marker for early detection of
LC, mainly in NSCLC20.
In conclusion, chromosomal regions were found
with high frequency of LOH where TSG involved in LC
development are probably located. This work will permit
conducting another study in which the number of samples
is increased and comparing to a control group with
similar characteristics as the cases, together with increa-
sing the number of informative microsatellite markers
for the Colombian population to narrow a minimal
region to a  few hundred base pairs to permit identifying
some yet unknown gene important in lung carcino-
genesis, because it was determined that LOH
phenomenon is a critical and early genetic event for
onset and development of the disease. Detecting LOH
in tissues of normal appearance surrounding tumor
tissue or in tissues with early stages of the disease will
lead to early diagnosis and to efficient preventive and
curative treatment. Finally, it must be stressed that this
is a pioneering study on LOH conducted in a Colombian
population.
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